Founders and brand teams usually ask one question first: how long will this take? The honest answer is a range, and the range depends less on how hard each stage is than on which stages can overlap and how often the work loops back. This guide sets out the food product development timeline stage by stage, shows which durations come from published lead times and which are project estimates, and explains what adds months. For the steps of the process itself, see our food product development process guide; for the formulation stage in depth, see from product brief to stable prototype.
In FRL’s experience, most projects take several months to more than a year from signed brief to launch. A line extension on proven ingredients sits at the short end; a novel format, a new ingredient or a long shelf-life claim sits at the long end. This is FRL’s working range, not a published benchmark, and every project is quoted on its own critical path.
The critical path is the longest chain of dependent tasks. The total is set by that chain, not by the sum of every stage, so overlap matters as much as effort. As a rough upper estimate, total ≈ T1 + T2 + the longest of T3, T4 and T5, where T1 to T5 are the five stage durations below (FRL planning rule).
Three variables dominate.
Rework and failure are real, but treat headline failure rates with care: a 2022 literature review found that the widely repeated claim that 90% of new products fail is not supported by empirical evidence.[4]
A stage-gate process moves a project from concept to launch through stages, each closed by a go or stop decision at a gate. FRL’s five food product development stages overlap on purpose: supplier qualification, label drafting and approval filing start before testing ends (Figure 1).
This stage produces a signed brief with measurable targets, a feasibility check on ingredients, claims, process and regulatory status, and a concept shortlist. It is usually the shortest stage, but every later gate is judged against it, so a vague brief is the most common source of later loops (FRL view).
Benchtop work changes one named factor per trial and ends when a version meets its pH, water activity, texture and sensory targets in replicate batches. Its length depends on how many iterations the concept needs, which is why FRL sets it at scoping rather than quoting a fixed figure. The method is covered in our guide from product brief to stable prototype.
Sensory panels report quickly; stability does not. Ireland’s food safety authority recommends testing at least three replicate samples from three separate production batches at each interval of a durability study.[5] Accelerated studies shorten the wait but still run for weeks: dried coconut chips were stored at 35, 45 and 55 °C for 15 weeks,[6] and corn snack bars at 10, 30 and 47 °C for 35 days.[7] See our guide to real-time and accelerated shelf-life testing.
Pilot runs test the formula on production-type equipment and give the first representative batches for stability and approval files. Mixing, heating and shear differ between a bench and a production line, so FRL re-measures the key quality targets at pilot scale (FRL practice). The risk is real: the grape study above found significant lab-to-pilot differences in texture, pH and sugar–acid ratio.[3] For a worked example, see how to scale up a recipe from kitchen batch to pilot plant.
Regulatory and label work can run alongside testing, so check the product’s status early. In India, the label must carry the date of manufacture or packing and the expiry or use-by date, and must state special storage conditions where the validity of the date depends on them.[8] Our FSSAI product approval guide covers the non-specified food route.
| Stage | Gate to pass | Overlaps with | Duration basis |
|---|---|---|---|
| 1. Brief and feasibility | Signed brief with measurable targets | Supplier enquiries | Set at scoping by concept novelty (FRL) |
| 2. Formulation and benchtop | Targets met in replicate batches | Supplier qualification, label draft | Set at scoping by expected iterations (FRL) |
| 3. Sensory, shelf-life and stability | End points met with margin | Pilot planning, approval filing | Real-time: beyond the target shelf life[1]; accelerated: 35 days to 15 weeks in two published studies[6][7] |
| 4. Scale-up and pilot | Pilot batch reproduces targets | Stability data collection | Set at scoping by equipment access (FRL) |
| 5. Approvals and launch | Approval held, label final | Stages 2 to 4 (label draft from Stage 2) | India: licence 60 days, non-specified food 4–6 months[2]; US GRAS notice: FDA response within 180 days of filing[9] |
Only stages 3 and 5 have published lead times. Stages 1, 2 and 4 depend on the product and the partner, so ask for the assumptions behind any figure quoted for them.
Shelf-life testing is often the longest single block. For a short-life chilled product, the real-time study has to run beyond the claimed shelf life, so a 12-day claim needs more than 12 days of data.[1] For long-life ambient products, which could take many months or years to reach the end of their shelf life, accelerated testing may be more appropriate, but it needs specialist storage equipment.[1] Either way, the clock starts only when the formula and pack are frozen, and a reformulation after that restarts it (FRL view).
A new ingredient needs a supplier specification and qualification before a trial, and sometimes its own approval. For a non-specified food in India, FSSAI informs the applicant of deficiencies within 45 days of receiving the application, and the applicant has 30 days to reply unless FSSAI extends that period.[10] The Citizen’s Charter lists 4–6 months overall, and 9–12 months for foods for special medical purposes.[2] In the US, where a company files a GRAS notice, FDA responds within 180 days of filing and may extend that by 90 days.[9] In August 2026 FDA proposed making GRAS notification mandatory for most substances; comments close on 9 December 2026, and the rule is not yet final.[11]
Formulator’s note: write the claim before the study. Fix the target shelf life, pack and storage conditions at the first gate. Those three decisions set the length of the stability study, so changing any of them later restarts the clock.
A change of pack, claim or target market after testing starts reopens stability, label and approval work. Fix the brief at the first gate, log each change with its reason, and change one factor per trial so that a failure points to its cause (FRL view).
The timeline shrinks through overlap and fewer loops, not shorter tests. Safety and stability work cannot be skipped. Five moves help (FRL practice):
Expect a plan with stages, a critical path and named gates, not a single date. A credible new product development timeline shows which durations come from published lead times and which from the partner’s own projects.
A food product development timeline is set by its critical path, not by the sum of its stages. Shelf-life studies, scale-up and approvals usually decide the launch date, and late changes to the claim, pack or market are the most common reason they slip. Fix those three at the first gate, run work in parallel where it is safe, and ask every partner which durations are published lead times and which are their own estimates.
If you are planning a new food or beverage launch, FRL can map your project into stages, gates and a critical path before work starts, so you know which durations are fixed and which you can influence.
Start with FRL’s food product development service, add a shelf-life study for the finished product, or contact the team to scope the project.
In FRL’s experience, most food products take several months to more than a year from brief to launch. Simple line extensions are faster; new ingredients, approvals or long shelf-life claims push the timeline out. Published lead times exist mainly for stability studies and approvals.
The main time-adders are real-time shelf-life studies, new-ingredient sourcing and approvals, and reformulation loops caused by scope changes or failed trials. A change of pack, claim or market after testing starts usually restarts stability work.
Yes, within limits. Accelerated screening, early supplier qualification and a fixed brief reduce delay, but safety and stability work cannot be skipped. The savings come from overlap and from avoiding rework.